全球远距手术市场－2026-2031年预测

全球远距手术市场预计将从 2025 年的 145.21 亿美元成长到 2031 年的 365.58 亿美元，复合年增长率为 16.64%。

全球远距手术市场融合了先进的机器人技术、通讯技术和外科手术科学，彻底模式转移了复杂手术的实施方式。在对外科创新持续成长的需求、对更便利的专科医疗服务以及技术日趋成熟的推动下，该市场正经历显着扩张。远端手术（也称为果冻或远端手术技术）利用先进的机器人系统和高清通讯网络，使外科医生能够为远在异地的患者实施微创手术。

市场核心动态与关键成长要素

市场成长受多种相互关联的强大因素所驱动。其中最重要的是各外科专科对微创手术日益增长的需求。患者和医疗服务提供者都希望获得诸如切口更小、创伤更小、疤痕更少、住院时间更短以及康復更快等益处。远距手术平台（主要是机器人辅助系统）的设计初衷正是为了促进这种手术方式，它们能够提供传统腹腔镜手术难以完成的复杂微创技术所需的精准度、灵活性和可视性。

这与人们对机器人辅助手术日益增长的认识及其临床疗效的证实密不可分。外科医生和医疗机构越来越意识到机器人辅助手术的技术优势，例如手术精确度、防手震和更佳的人体工学设计。随着临床证据的不断积累，机器人辅助手术的普及门槛正在降低，从而促进了基于现有基础的下一代远距手术平台的接受度。

此外，全球对先进医疗基础设施投资的不断增加，正在建立推广应用所需的生态系统。部署远端手术系统不仅需要对技术本身进行资本投入，还需要强大的数位基础设施，包括高频宽、低延迟的通讯网路和整合的医院资讯系统。对手术室现代化和通讯能力的策略性投资将是市场渗透的关键驱动力。

远距手术的强大驱动力在于其在医疗服务效率和可及性方面具有变革性的潜力。远距手术有望克服地域障碍，将世界一流的外科专家带到偏远农村和医疗资源匮乏地区的患者身边，无需他们奔波。这可以优化稀缺外科专家的利用，减少医疗服务的系统性延误，并透过集中化的专家资源和更有效率的患者就诊流程，为医疗系统节省大量成本。

市场区隔与竞争格局

市场按组件类型、应用、最终用户和地区进行细分。主要细分市场包括机器人系统（资本设备）、相关仪器和配件，以及配套软体和服务。最终用户主要为大型医院和教学医院，门诊手术中心也具有成长潜力。

竞争格局呈现出既有成熟的医疗机器人产业领导企业，也有创新新兴参与企业的并存态势。直觉外科公司（Intuitive Surgical Inc.）凭藉其达文西手术系统，开创并建立了机器人辅助微创手术市场，从而维持了其历史优势。其他主要医疗技术公司，例如美敦力公司（Medtronic，其Hugo平台）和捷迈生物（Zimmer Biomet，其ROSA系统），分别致力于推进专注于普通外科和整形外科/神经外科的竞争平台。研究机构和技术开发商，例如SRI国际，正在贡献基础性创新，探索下一代远距手术概念。竞争的核心在于技术差异化、手术操作的多样性、成本效益以及临床训练和支援体系的深度。

地理视角：北美主导潮流

北美在全球远距手术市场保持主导地位。这项优势源自于一系列结构性优势：主要市场参与者和研究机构高度集中；医疗基础设施完善，技术普及率高；医疗支出庞大；以及复杂但完善的报销环境，为先进外科技术建立了成熟的报销机制。该地区对外科创新和新型医疗设备早期应用的重视，巩固了其作为关键市场和下一代系统试验场的地位。

未来展望及战略意义

远端手术市场即将超越目前仅限于单一手术室内的机器人辅助手术模式。未来的发展将朝着真正的远端手术迈进，而超可靠、低延迟的通讯网路（例如5G及未来技术）将为此提供有力支持。这将需要触觉回馈技术的进步、用于决策支援和安全保障的增强型人工智慧以及强大的网路安全通讯协定。

对于产业相关人员，策略成功不仅取决于展现卓越的临床疗效，还取决于透过提高营运效率和扩大患者覆盖范围来展现显着的经济价值。建立严格的远端手术监管路径、实施标准化的培训和认证通讯协定，以及确保系统与现有医院工作流程的无缝集成，将是关键挑战。随着远距手术技术从先进工具转型为网路化医疗服务平台，它将重新定义外科手术的边界，使专业、高品质的医疗介入在全球范围内更加便捷和高效。

本报告的主要优势：

• 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要企业的策略倡议，并了解透过正确的策略进入市场的可能性。
• 市场驱动因素与未来趋势：探索推动市场的动态因素和关键趋势，以及它们将如何塑造未来的市场发展。
• 可操作的建议：利用这些见解，在动态环境中製定策略决策，发展新的业务流和收入来源。
• 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

企业使用我们的报告的目的是什么？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

• 2021年至2025年的实际数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区分類的收入和预测评估，包括国家/地区
• 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

第五章 全球远距手术市场（按类型划分）

• 介绍
• 机器人系统
• 仪器和配件
• 其他的

6. 全球远距手术市场（按应用划分）

• 介绍
• 妇科手术
• 泌尿系统手术
• 整形外科手术
• 心血管外科
• 神经外科
• 胃肠外科手术
• 其他的

7. 按最终用户分類的全球远端手术市场

• 介绍
• 医院
• 门诊手术中心
• 研究所
• 其他的

8.按地区分類的全球远距手术市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• Intuitive Surgical, Inc.
• Stryker Corporation
• Medtronic plc
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson Services, Inc.
• Smith & Nephew plc
• TransEnterix Surgical, Inc.
• Verb Surgical Inc.（a joint venture between Verily Life Sciences and Johnson & Johnson）
• Medrobotics Corporation
• Titan Medical Inc.

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

The global remote surgery market, with a 16.64% CAGR, is anticipated to reach USD 36.558 billion in 2031 from USD 14.521 billion in 2025.

The global remote surgery market represents the convergence of advanced robotics, telecommunications, and surgical science, creating a paradigm shift in how complex procedures are delivered. This market is experiencing significant expansion, driven by a persistent demand for surgical innovation, the imperative to democratize access to specialist care, and substantial technological maturation. Remote surgery, also referred to as telesurgery or teleoperated surgery, utilizes sophisticated robotic systems and high-fidelity communication networks to enable surgeons to perform minimally invasive procedures on patients located at a physical distance.

Core Market Dynamics and Primary Growth Drivers

The market's growth is propelled by several powerful, interrelated forces. Foremost is the increasing demand for minimally invasive procedures across surgical specialties. Patients and providers alike seek the benefits of smaller incisions, reduced trauma, diminished scarring, shorter hospital stays, and faster recovery times. Remote surgical platforms, predominantly robotic-assisted systems, are inherently designed to facilitate this approach, offering the enhanced precision, dexterity, and visualization required for complex minimally invasive techniques that can be challenging with traditional laparoscopy.

This is closely linked to the growing acceptance and proven clinical validation of robotic-assisted surgery. Surgeons and healthcare institutions increasingly recognize the technological advantages in terms of procedural accuracy, tremor filtration, and improved ergonomics. As clinical evidence demonstrating positive patient outcomes accumulates, the adoption barrier lowers, fostering a receptive environment for next-generation telesurgery platforms that build upon this established foundation.

Furthermore, rising global investments in advanced healthcare infrastructure are creating the necessary ecosystem for adoption. The deployment of remote surgery systems requires not only capital investment in the technology itself but also robust digital infrastructure, including high-bandwidth, low-latency communication networks and integrated hospital information systems. Strategic investments in modernizing surgical suites and telecommunications capabilities are critical enablers for market penetration.

A compelling driver is the potential for transformative efficiency and access in healthcare delivery. Remote surgery holds the promise of overcoming geographical barriers, allowing world-class surgical expertise to be delivered to patients in rural, remote, or underserved areas without the need for travel. This can optimize the utilization of scarce surgical specialists, reduce systemic delays in care, and potentially generate significant cost savings for healthcare systems by centralizing expertise and streamlining patient pathways.

Market Segmentation and Competitive Landscape

The market is segmented by component type, application, end-user, and geography. Key segments include the robotic systems themselves (the capital equipment), the associated instruments and accessories, and supporting software and services. End-users are primarily large hospitals and academic medical centers, with growing potential in ambulatory surgical centers.

The competitive landscape is characterized by a mix of established medical robotics leaders and innovative entrants. Intuitive Surgical Inc., with its da Vinci Surgical System, holds a historically dominant position, having pioneered and validated the market for robotic-assisted minimally invasive surgery. Other major medical technology companies, such as Medtronic with its Hugo platform and Zimmer Biomet with its ROSA systems, are advancing competitive platforms with specific focuses on general surgery and orthopedics/neurosurgery, respectively. Research institutions and technology developers like SRI International contribute to foundational innovation, exploring next-generation telesurgery concepts. Competition centers on technological differentiation, procedural versatility, cost-effectiveness, and the depth of clinical training and support ecosystems.

Geographical Outlook: North American Leadership

North America maintains a leadership position in the global remote surgery market. This dominance is attributed to a confluence of structural advantages: a concentration of leading market players and research institutions, a well-developed healthcare infrastructure with high technological adoption rates, substantial healthcare expenditure, and a reimbursement environment that, while complex, has established pathways for advanced surgical technologies. The region's focus on surgical innovation and early adoption of new medical devices solidifies its role as the primary market and a testing ground for next-generation systems.

Future Trajectory and Strategic Implications

The remote surgery market is poised for continued evolution beyond its current state, which is largely defined by robotic-assisted surgery within a single operating room. The future trajectory points toward true long-distance telesurgery, enabled by ultra-reliable, low-latency communication networks (e.g., 5G and beyond). This will necessitate advancements in haptic feedback, enhanced artificial intelligence for decision support and safety, and robust cybersecurity protocols.

For industry participants, strategic success will depend on demonstrating not only superior clinical outcomes but also compelling economic value through improved operational efficiency and expanded patient reach. Navigating rigorous regulatory pathways for true remote operations, establishing standardized training and credentialing protocols, and ensuring seamless system integration within existing hospital workflows will be critical challenges. As the technology transitions from an advanced tool to a networked care delivery platform, remote surgery is set to redefine the boundaries of surgical practice, making specialized, high-quality intervention more accessible and efficient on a global scale.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Remote Surgery Market Segmentation

• By Type
• Robotic Systems
• Instruments and Accessories
• Others
• By Application
• Gynecology Surgery
• Urology Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Neurology Surgery
• Gastrointestinal Surgery
• Others
• By End-User
• Hospitals
• Ambulatory Surgical Centers
• Research Institutes
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL REMOTE SURGERY MARKET BY TYPE

• 5.1. Introduction
• 5.2. Robotic Systems
• 5.3. Instruments and Accessories
• 5.4. Others

6. GLOBAL REMOTE SURGERY MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Gynecology Surgery
• 6.3. Urology Surgery
• 6.4. Orthopedic Surgery
• 6.5. Cardiovascular Surgery
• 6.6. Neurology Surgery
• 6.7. Gastrointestinal Surgery
• 6.8. Others

7. GLOBAL REMOTE SURGERY MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centers
• 7.4. Research Institutes
• 7.5. Others

8. GLOBAL REMOTE SURGERY MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Intuitive Surgical, Inc.
• 10.2. Stryker Corporation
• 10.3. Medtronic plc
• 10.4. Zimmer Biomet Holdings, Inc.
• 10.5. Johnson & Johnson Services, Inc.
• 10.6. Smith & Nephew plc
• 10.7. TransEnterix Surgical, Inc.
• 10.8. Verb Surgical Inc. (a joint venture between Verily Life Sciences and Johnson & Johnson)
• 10.9. Medrobotics Corporation
• 10.10. Titan Medical Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations